Literature DB >> 27836772

Return to play in athletes with spinal cord concussion: a systematic literature review.

Narihito Nagoshi1, Lindsay Tetreault2, Hiroaki Nakashima3, Aria Nouri2, Michael G Fehlings4.   

Abstract

STUDY
DESIGN: This is a systematic review.
PURPOSE: The study aimed to evaluate whether spinal cord concussion (SCC) patients can safely return to play sports and if there are factors that can predict SCC recurrence or the development of a spinal cord injury (SCI). BACKGROUND CONTEXT: Although SCC is a reversible neurologic disturbance of spinal cord function, its management and the implications for return to play are controversial.
METHODS: We conducted a systematic search of the literature using the keywords Cervical Spine AND Sports AND Injuries in six databases. We examined return to play in patients (1) without stenosis, (2) with stenosis, and (3) who underwent single-level anterior cervical discectomy and fusion (ACDF). We also investigated predictors for the risk of SCC recurrence or SCI.
RESULTS: We identified 3,655 unique citations, 16 of which met our inclusion criteria. The included studies were case-control studies or case series and reports. Two studies reported on patients without stenosis: pediatric cases returned without recurrence, whereas an adult case experienced recurrent SCC after returning to play. Seven studies described patients with stenosis. These studies included cases with and without recurrence after return to play, as well as patients who suffered SCI with permanent neurologic deficits. Three studies reported on patients who underwent an ACDF. Although some patients played after surgery without problems, several patients experienced recurrent SCC due to herniation at levels adjacent to the surgical sites. With respect to important predictors, a greater frequency of patients who experienced recurrence of symptoms or SCI following return to play had a "long" duration of symptoms (>24 hours; 36.36%) compared with those who were problem-free (11.11%; p=.0311).
CONCLUSIONS: There is limited evidence on current practice standards for return to play following SCC and important risk factors for SCC recurrence or SCI. Because of small sample sizes, future prospective multicenter studies are needed to determine important predictive factors of poor outcomes following return to play after SCC.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Cervical stenosis; Neurapraxia; Return to play; Spinal cord concussion; Surgical treatment; Systematic review

Mesh:

Year:  2016        PMID: 27836772     DOI: 10.1016/j.spinee.2016.09.013

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  5 in total

1.  Football (soccer)-related spinal cord injury-reported cases from 1976 to 2020.

Authors:  Manoj K Poudel; Andrew L Sherman
Journal:  Spinal Cord Ser Cases       Date:  2020-11-30

2.  A case of real spinal cord injury without radiologic abnormality in a pediatric patient with spinal cord concussion.

Authors:  Hiroki Nagasawa; Kouhei Ishikawa; Ryosuke Takahashi; Ikuto Takeuchi; Kei Jitsuiki; Hiromichi Ohsaka; Kazuhiko Omori; Youichi Yanagawa
Journal:  Spinal Cord Ser Cases       Date:  2017-08-17

3.  Cervical Spine Injuries in the Ice Hockey Player: Current Concepts in Epidemiology, Management and Prevention.

Authors:  Cole Morrissette; Paul J Park; Ronald A Lehman; Charles A Popkin
Journal:  Global Spine J       Date:  2020-11-18

4.  The Relationship between Physical Activity Level and Functional Status of Subjects with High Spinal Cord Injury.

Authors:  Ewa Szeliga; Agnieszka Brzozowska-Magoń; Renata Borys; Andżelina Wolan-Nieroda; Katarzyna Walicka-Cupryś
Journal:  Int J Environ Res Public Health       Date:  2022-02-04       Impact factor: 3.390

5.  The influence of timing of surgery in the outcome of spinal cord injury without radiographic abnormality (SCIWORA).

Authors:  Can Qi; Hehuan Xia; Dechao Miao; Xingui Wang; Zengyan Li
Journal:  J Orthop Surg Res       Date:  2020-06-16       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.